Literature DB >> 20645063

The application of HepRG cells in evaluation of cytochrome P450 induction properties of drug compounds.

Tommy B Andersson1.   

Abstract

The liver is the major organ metabolising drugs. The hepatocyte contains a number of drug-metabolising enzyme systems, which most often generate a complex pattern of drug metabolites. Isolated primary hepatocytes would be an ideal in vitro model for drug metabolism research but erratic availability and poor stability of functions in culture limit their value. Recently a hepatoma cell line HepaRG was developed showing promising functions and stability. In the differentiated stage the cell line showed stable expression of mRNA coding for key proteins in drug metabolism and liver-specific functions for over 6 weeks. The cell line was found to reflect important hepatic functions and has been evaluated as a convenient model for evaluating cytochrome P450 induction properties of drug compounds. HepaRG cells could therefore be an alternative to human hepatocytes in investigating drug metabolism and induction of drug-metabolising enzymes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20645063     DOI: 10.1007/978-1-60761-688-7_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Protective effects of an ethanol extract of Angelica keiskei against acetaminophen-induced hepatotoxicity in HepG2 and HepaRG cells.

Authors:  Yoon-Hee Choi; Hyun Sook Lee; Cha-Kwon Chung; Eun Ji Kim; Il-Jun Kang
Journal:  Nutr Res Pract       Date:  2017-03-10       Impact factor: 1.926

2.  Utility of B-13 progenitor-derived hepatocytes in hepatotoxicity and genotoxicity studies.

Authors:  Philip M E Probert; Git W Chung; Simon J Cockell; Loranne Agius; Pasquale Mosesso; Steven A White; Fiona Oakley; Colin D A Brown; Matthew C Wright
Journal:  Toxicol Sci       Date:  2013-11-14       Impact factor: 4.849

3.  MicroRNA Mediated Changes in Drug Metabolism and Target Gene Expression by Efavirenz and Rifampicin In Vitro: Clinical Implications.

Authors:  Marelize Swart; Collet Dandara
Journal:  OMICS       Date:  2019-09-16

4.  Targeting the pregnane X receptor using microbial metabolite mimicry.

Authors:  Zdeněk Dvořák; Felix Kopp; Hao Li; Aneta Vrzalová; Cait M Costello; Jazmin S Kemp; Martina Štěpánková; Iveta Bartoňková; Eva Jiskrová; Karolína Poulíková; Barbora Vyhlídalová; Lars U Nordstroem; Chamini V Karunaratne; Harmit S Ranhotra; Kyu Shik Mun; Anjaparavanda P Naren; Iain A Murray; Gary H Perdew; Julius Brtko; Lucia Toporova; Arne Schön; Bret D Wallace; William G Walton; Matthew R Redinbo; Katherine Sun; Amanda Beck; Sandhya Kortagere; Michelle C Neary; Aneesh Chandran; Saraswathi Vishveshwara; Maria M Cavalluzzi; Giovanni Lentini; Julia Yue Cui; Haiwei Gu; John C March; Shirshendu Chatterjee; Adam Matson; Dennis Wright; Kyle L Flannigan; Simon A Hirota; Ryan Balfour Sartor; Sridhar Mani
Journal:  EMBO Mol Med       Date:  2020-03-10       Impact factor: 12.137

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.